Newsfeeds Archive - Page 2 of 2

3 minute read

10 Short Squeeze Candidates That May Soar: Athersys, TDH Holdings, FaZe Holdings, Weber And More

September 12, 11:22 AM

Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates for the week of Sept. 12, according to Fintel Data:

ATHX

3 minute read

Revlon Climbs, Singing Machine Moves Up And Weber Makes Big Move: 5 Short Squeeze Stocks That May Soar This Week

By Chris Katje

August 22, 11:16 AM

Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move.

CMRA

4 minute read

Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

July 13, 12:21 PM

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

ACON

3 minute read

This Healthcare Stock is Down By More Than 50%: Here’s 25 Stocks Moving Premarket

By Lisa Levin

July 13, 6:22 AM

Gainers

ABVC

6 minute read

Boeing, PriceSmart And 80 Biggest Movers From Yesterday

By Lisa Levin

July 13, 4:59 AM

Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share.

AAL

3 minute read

Crude Oil Prices Fall Sharply; Greenwich LifeSciences Shares Spike Higher

By Lisa Levin

July 12, 2:39 PM

U.S. stocks traded mixed toward the end of trading after recording losses in the previous session.

ETWO

1 minute read

Here’s Why Greenwich Lifesciences Shares Are Popping Off Today

By Henry Khederian

July 12, 1:07 PM

Greenwich Lifesciences Inc (NASDAQ: GLSI) shares are trading higher by 32.95% to $11.46 Tuesday afternoon after the FDA removed the clinical hold on the company's Flamingo-01 Phase 3 trial of GP2.

GLSI

1 minute read

FDA
News

UPDATE: Greenwich LifeSciences Says FDA Is Currently Reviewing Manufacturing Data, Has Sent Co. Follow Up Questions To Which Co. Has Responded; Co. Says 3rd Lot Was Manufactured In Commercial Facility On Automated Filling Line

By Michael Horton

July 11, 5:11 PM

-Reuters

GLSI

1 minute read

News

Greenwich LifeSciences Says Completed Last Steps Of Manufacturing GP2, Says Released Three Clinical Lots Of GP2 Drug Product That Co. Believes Meet All Release Specifications

By Michael Horton

July 11, 5:10 PM

-Reuters

GLSI

1 minute read

Greenwich LifeSciences Announces Suspension of Share Repurchase Program

By Bill Haddad

July 11, 4:16 PM

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, announced that its Board of Directors has suspended the

GLSI